Aroxybutynin

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C22H31NO3
Molecular Weight	357.4864
Optical Activity	( - )
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CCN(CC)CC#CCOC(=O)[C@@](O)(C1CCCCC1)C2=CC=CC=C2

InChI

InChIKey=XIQVNETUBQGFHX-QFIPXVFZSA-N

InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m0/s1

HIDE SMILES / InChI

Approval Year

PubMed

Show entries

Title	Date	PubMed
Augmentation ureterocystoplasty in bladder exstrophy: 5-year follow-up in two cases.	2002 Dec	12477661
Oxybutynin transdermal (Oxytrol) for overactive bladder.	2003 May 12	12736598
[Prevalence of urinary incontinence and linked factors in men and women over 65].	2003 Oct 15	14572396
Prediction of genotoxicity of chemical compounds by statistical learning methods.	2005 Jun	15962942
Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.	2007 Sep	17360104

Showing 1 to 5 of 8 entries

Previous1 2Next

Patents

Show entries

Name

Type

Language

(-)-OXYBUTYNIN

Preferred Name

English

Aroxybutynin

Official Name

English

OXYBUTYNIN, (-)-

Common Name

English

AD-109 component Aroxybutynin

Code

English

4-(diethylamino)but-2-yn-1-yl (R)-cyclohexyl(hydroxy)(phenyl)acetate

Systematic Name

English

Showing 1 to 5 of 10 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

FDA UNII

5BRQ29UUB7

PRIMARY

CAS

119618-21-2

PRIMARY

SMS_ID

300000045599

PRIMARY

INN

12152

PRIMARY

PUBCHEM

6098167

PRIMARY

Showing 1 to 5 of 6 entries

Previous1 2Next

ACTIVE MOIETY


					5BRQ29UUB7

Aroxybutynin